IMMUNE THERAPEUTICS INCORPORATED FLA
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IMMUNE THERAPEUTICS INCORPORATED FLA Equity, CUSIP 45252A107.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for IMMUNE THERAPEUTICS INCORPORATED FLA Equity, CUSIP 45252A107.